Concurrent chemotherapy with hyperfractionated accelerated thoracic irradiation in stage III non-small cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Concurrent chemotherapy with hyperfractionated accelerated thoracic irradiation in stage III non-small cell lung cancer

Published:1999-01 Issue:1 Volume:23 Page:19-30
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Lochrin Catherine,Goss Glenwood,Stewart David J.,Cross Peter,Agboola Olusegun,Dahrouge Simone,Tomiak Eva,Evans W.K.

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference38 articles.

1. Phase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable non-small cell lung cancer: a hoosier oncology group protocol;Blanke;J. Clin. Oncol.,1995

2. Comparison of induction chemotherapy before radiotherapy with radiotherapy only in patients with locally advanced squamous cell carcinoma of the lung. The Swedish lung cancer study group;Brodin;Eur. J. Cancer,1996

3. Peripheral neuropathy and ototoxicity of dichlorodiamineplatinum: instrumental evaluation. Preliminary results;Carenza;Gynecol. Oncol.,1986

4. A randomized phaseI/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with≥69.6 Gy in favorable patients with radiation therapy oncology group stage III non-small-cell lung carcinoma: report of radiation therapy oncology group 83–11;Cox;J. Clin. Oncol.,1990

5. Induction chemotherapy plus high-dose radiotherapy versus radiotherapy alone in locally advanced unresectable non-small-cell lung cancer;Crino;Annals. Oncol.,1993

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Consolidation Systemic Therapy in Locally Advanced, Inoperable Nonsmall Cell Lung Cancer—How to Identify Patients Which Can Benefit from It?;Current Oncology;2022-10-31

2. Chemoradiotherapy for Inoperable Non-small Cell Lung Cancer;Lung Cancer;2010

3. The Pulmonary Toxicity of Anticancer Agents;Comprehensive Toxicology;2010

4. Five-Year Results of a Phase II Trial of Hyperfractionated Radiotherapy and Concurrent Daily Cisplatin Chemotherapy for Stage III Non-Small-Cell Lung Cancer;American Journal of Clinical Oncology;2005-06

5. Pilot Study of Accelerated Radiotherapy With Concurrent Chemotherapy for Stage III Non-Small Cell Lung Cancer;Seminars in Oncology;2005-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3